Mastodawn

PharmaResearch shares plunged over 10% after a Q4 earnings miss, with the stock now down more than 40% from its 52-week high amid growth concerns.
#YonhapInfomax #PharmaResearch #EarningsMiss #OperatingProfit #NextTrade #52WeekHigh #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=103832

PharmaResearch Plunges 10% on Earnings Miss—Shares Down Over 40% from 52-Week High

PharmaResearch shares plunged over 10% after a Q4 earnings miss, with the stock now down more than 40% from its 52-week high amid growth concerns.

Yonhap Infomax

Kalkine Pty Ltd Jul 21, 2025

TSX 52 Week High Performers Worth Watching

Explore the current list of tsx 52 week high performers. The compilation highlights listed companies that have reached their highest price point in the past year. It’s a quick snapshot of momentum across sectors and industries on the TSX index, tracked over a 52-week timeframe.

visit: https://kalkine.ca/companies/52-week-high/

#TSX #TSXStocks #StockMarketCanada #52WeekHigh #TSXMarket #CanadianMarkets #MarketUpdate #StockHighlights #TSXTrends #EquityWatch

TSX 52 Week High: Identifying Strong Performers | Kalkine

Identify TSX stocks at their 52-week highs, signaling robust performance and potential investment opportunities. Stay updated with Kalkine's insightful analysis and expert insights.

Kalkine